Technology | Digital Radiography (DR) | February 21, 2019

Agfa Receives FDA Clearance for DR 800 With Tomosynthesis

Agfa’s tomosynthesis for digital radiography uses iterative reconstruction for fast multi-slice image reconstruction with less noise and fewer artifacts

Agfa Receives FDA Clearance for DR 800 With Tomosynthesis

February 21, 2019 — Agfa Healthcare has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its DR 800 multipurpose digital radiography (DR) imaging system with tomosynthesis. Offering one solution for radiography, fluoroscopy, multi-slice and advanced clinical applications, the DR 800 supports the role of radiology in the value-based care organization with increased versatility, functionality and efficiency.

With the DR 800, Agfa moves from 2-D single-plane imaging to multi-slice image reconstruction. Tomosynthesis is used to synthesize tomographic slices from a single tomographic sweep.

The DR 800 includes Agfa’s brand-new tomosynthesis algorithms for iterative reconstruction, which deliver images with less noise and fewer artifacts. These algorithms also enable very fast image reconstruction in less than one minute, overcoming the usual slow iterative reconstruction process.

The system comes standard with Dynamic MUSICA, for both static and dynamic images. This image processing software enhances noise suppression, offers superb brightness control, reduces veiling glare, and plays a significant role in enabling potential dose reduction.

Dynamic MUSICA includes MUSICA Digital TomoSynthesis software, which powers the tomosynthesis reconstruction, automatically presenting images with optimal contrast, and providing consistent image quality across the individual slices and images.

The fully integrated DR 800 offers a multipurpose digital imaging solution that can handle a full range of radiography (including static exams and tilting exams) and fluoroscopy exams (including barium meals, swallows and enemas, arthrograms and cystourethrograms, myelography and catheter placement, etc.), as well as tomosynthesis exams.

The DR 800 is not available in Canada.

For more information: www.agfahealthcare.com

Related Content

Videos | Radiology Business | March 22, 2019
American Society of Radiologic Technologists (ASRT) President Melissa Jackowski, Ed.D., R.T.(R)(M), FASRT, explains e
FDA Clears Mobilett Elara Max Mobile X-ray from Siemens Healthineers
Technology | Digital Radiography (DR) | March 20, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Mobilett Elara Max mobile X-ray system from Siemens...
Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...
Fujifilm Launches Three New Software Tools for Aspire Cristalle Digital Mammography System
Technology | Mammography | March 15, 2019
Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory...
Sponsored Content | Videos | Enterprise Imaging | March 15, 2019
As a VNA, GE Healthcare Ce
Canon Medical Introduces Entry-Level Aquilion Start CT
News | Computed Tomography (CT) | March 14, 2019
Canon Medical Systems Europe B.V. introduced the all-new Aquilion Start computed tomography (CT) system to the European...
Siemens Healthineers Debuts Cardiovascular Edition of Somatom go.Top CT
News | Computed Tomography (CT) | March 14, 2019
Siemens Healthineers will introduce the Somatom go.Top Cardiovascular Edition, a new version of its established...
Esaote Introduces MyLab X8 Ultrasound Platform
News | Ultrasound Imaging | March 13, 2019
Esaote announced the launch of MyLab X8, a high-performance, versatile ultrasound platform to support hospitals and...
Sponsored Content | Videos | Artificial Intelligence | March 13, 2019
At RSNA 2018, iCad showed how its...
Iron Measurements With MRI Reveal Stroke's Impact on Brain

Images show illustrative examples of visual R2? modifications within substantia nigra (SN) at baseline (24-72 h) and follow-up (1 y) in striatum (participants 1 and 2) and control groups (participants 3 and 4). Image courtesy of the Radiological Society of North America (RSNA).

News | Stroke | March 12, 2019
March 12, 2019 — A simple ...